It is known that the Tsc2-/- tumors in this mouse model have constitutively activated mTOR kinase [20], and a similar defect in mTOR signaling is observed in brain and kidney tumors associated with TSC [31,32]. This evidence concerns the gene TSC1 and kidney neoplasm.